Morgan Stanley issued a rating and price target for Trevi Therapeutics, Inc. on August 28, 2026.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley issued a rating and price target for Trevi Therapeutics, Inc. on August 28, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley provided price targets and ratings for Booking Holdings on September 22, 2026.
- Morgan Stanley downgraded the stock rating for Qfin Holdings, Inc. on September 9, 2026.
- Morgan Stanley and Royal Bank of Canada adjusted ratings and price targets for TransDigm Group Incorporated stock.
- Morgan Stanley set a price target on Q2 stock, while MarketBeat provided average rating data for Q2.
- Morgan Stanley and Bank of America raised price targets on NetApp shares, with MarketBeat reporting the consensus rating.